BRIX1 and urinary bladder cancer: To further elucidate how AR signals modulate chemosensitivity in urothelial cancer, we here investigated the functional role of a potential downstream effector, BXDC2, known to involve ribosome biogenesis, using bladder cancer cell lines and surgical specimens.